The biomarkers with the most evidence as highlighted in this paper which may have prognostic implications on breast cancer in older women include and are under reported in the current literature include: BCL2, cyclin E, EGFR, LKB1, MUC1 and CKs. Here, BCL2 is linked to breast cancer.